KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Cash & Current Investments: 2017-2025

Historic Cash & Current Investments for Guardant Health (GH) over the last 7 years, with Sep 2025 value amounting to $580.0 million.

  • Guardant Health's Cash & Current Investments fell 35.25% to $580.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 billion, marking a year-over-year decrease of 31.77%. This contributed to the annual value of $840.0 million for FY2024, which is 28.12% down from last year.
  • As of Q3 2025, Guardant Health's Cash & Current Investments stood at $580.0 million, which was down 7.81% from $629.1 million recorded in Q2 2025.
  • Guardant Health's 5-year Cash & Current Investments high stood at $1.9 billion for Q1 2021, and its period low was $580.0 million during Q3 2025.
  • Over the past 3 years, Guardant Health's median Cash & Current Investments value was $933.7 million (recorded in 2024), while the average stood at $917.4 million.
  • In the last 5 years, Guardant Health's Cash & Current Investments spiked by 273.10% in 2021 and then tumbled by 52.35% in 2022.
  • Guardant Health's Cash & Current Investments (Quarterly) stood at $932.7 million in 2021, then climbed by 8.41% to $1.0 billion in 2022, then rose by 15.57% to $1.2 billion in 2023, then dropped by 28.12% to $840.0 million in 2024, then plummeted by 35.25% to $580.0 million in 2025.
  • Its Cash & Current Investments stands at $580.0 million for Q3 2025, versus $629.1 million for Q2 2025 and $698.6 million for Q1 2025.